InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
0.00%
)
Bitcoin
63,700.00
(
-0.30%
)
Post# of 14871
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

big bambino

Send PM Follow Ignore
Followers 13
Posts 1903
Boards Moderated 0
Alias Born 03/03/2011

big bambino

Re: None

Tuesday, 11/06/2018 9:26:35 AM

Tuesday, November 06, 2018 9:26:35 AM

Post# of 14871
Back to News
ANI Pharma beats by $0.12, reports revs in-line; reaffirms FY18 EPS guidance, revs guidance
52 minutes ago Published 52 minutes ago
Briefing.com
Related Investments

ANI Pharmaceuticals Inc

Reports Q3 (Sep) earnings of $1.29 per share, excluding non-recurring items, $0.12 better than the S&P Capital IQ Consensus of $1.17; revenues rose 5.3% year/year to $50.7 mln vs the $50.97 mln S&P Capital IQ Consensus.Revenues from sales of generic pharmaceuticals decreased 1%, to $30.3 million from $30.5 million in the prior period, primarily due to volume decreases for Fenofibrate, EEMT, and Nilutamide, tempered by the second quarter 2018 launch of Ezetimibe-Simvastatin. Co reaffirms guidance for FY18, sees EPS of $4.80-5.27, excluding non-recurring items, vs. $4.91 S&P Capital IQ Consensus; sees FY18 revs of $195-205 mln vs. $200.03 mln S&P Capital IQ Consensus.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent ANIP News
More ANIP News
InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news
Only $200 per official company press release!